Myriad Genetics, Inc. (MYGN)
3.04
-0.16
(-5.00%)
USD |
NASDAQ |
Aug 24, 16:00
3.04
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics EPS Diluted (Quarterly) : -0.4557 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4557 |
| March 31, 2026 | -0.3639 |
| December 31, 2025 | -0.0847 |
| September 30, 2025 | -0.2943 |
| June 30, 2025 | -3.573 |
| March 31, 2025 | -0.0011 |
| December 31, 2024 | -0.4665 |
| September 30, 2024 | -0.2431 |
| June 30, 2024 | -0.4051 |
| March 31, 2024 | -0.2892 |
| December 31, 2023 | -0.3624 |
| September 30, 2023 | -0.7485 |
| June 30, 2023 | -1.421 |
| March 31, 2023 | -0.6728 |
| December 31, 2022 | -0.519 |
| September 30, 2022 | -0.4349 |
| June 30, 2022 | -0.1754 |
| March 31, 2022 | -0.2559 |
| December 31, 2021 | -0.0951 |
| September 30, 2021 | 0.3018 |
| June 30, 2021 | -0.0609 |
| March 31, 2021 | -0.5197 |
| June 30, 2020 | -0.7426 |
| March 31, 2020 | -1.546 |
| December 31, 2019 | -0.1116 |
| Date | Value |
|---|---|
| September 30, 2019 | -0.2795 |
| June 30, 2019 | -0.0572 |
| March 31, 2019 | 0.0921 |
| December 31, 2018 | 0.034 |
| September 30, 2018 | -0.0096 |
| June 30, 2018 | 0.1989 |
| March 31, 2018 | 0.1257 |
| December 31, 2017 | 0.4298 |
| September 30, 2017 | 1.119 |
| June 30, 2017 | 0.19 |
| March 31, 2017 | 0.06 |
| December 31, 2016 | 0.09 |
| September 30, 2016 | -0.02 |
| June 30, 2016 | 0.32 |
| March 31, 2016 | 0.47 |
| December 31, 2015 | 0.41 |
| September 30, 2015 | 0.37 |
| June 30, 2015 | 0.26 |
| March 31, 2015 | 0.29 |
| December 31, 2014 | 0.32 |
| September 30, 2014 | 0.21 |
| June 30, 2014 | 0.43 |
| March 31, 2014 | 0.48 |
| December 31, 2013 | 0.66 |
| September 30, 2013 | 0.68 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Natera, Inc. | -0.4674 |
| Sera Prognostics, Inc. | -0.181 |
| BioRestorative Therapies, Inc. | -0.1215 |
| CareDx, Inc. | 2.071 |
| Exagen, Inc. | -0.1323 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -43.20M |
| Revenue (Quarterly) | 190.70M |
| Total Expenses (Quarterly) | 233.90M |
| Enterprise Value | 401.22M |
| Gross Profit Margin (Quarterly) | 62.51% |
| Profit Margin (Quarterly) | -22.65% |
| Earnings Yield | -39.43% |
| Normalized Earnings Yield | -37.43 |